| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Agios Pharmaceuticals (NASDAQ:AGIO) through any online brokerage.
Other companies in Agios Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Agios Pharmaceuticals has a consensus price target of $45.58.
The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $31.8 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Agios Pharmaceuticals.
Agios Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Agios Pharmaceuticals.
Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
